Registration

18th Bleeding and Thrombosing Diseases is being held Oct. 4–6, 2023, at the Hilton Rochester Mayo Clinic Area. Classical Hematology 2023, another Mayo Clinic nonmalignant hematology conference, will be held immediately before the 18th Bleeding and Thrombosing Diseases Conference, from Oct. 3–4. Both conferences will be offered in person and via livestream.

Classical Hematology

October 3–4, 2023

Ends at 12:15 p.m. on Wednesday, Oct. 4

Bleeding and Thrombosing Diseases

October 4–6, 2023

Begins at 12:30 p.m. on Wednesday, Oct. 4

Attendees interested in a comprehensive review of nonmalignant hematology should consider attending both conferences for the best value. A price reduction is offered to attendees attending both conferences as detailed below.

Conference	Full Fee (M.D., Ph.D.)	Reduced Fee (Resident, Fellow, NP, PA, RN, etc.)
Bleeding and Thrombosing Diseases only October 4–6, 2023	$725	$625
Bleeding and Thrombosing Diseases discount rate* October 4–6, 2023	$625	$525
Classical Hematology only October 3–4, 2023	$425	$350
Classical Hematology discount rate* October 3–4, 2023	$325	$250

*Discount rate only applies if registrant is attending Classical Hematology (October 3–4, 2023) and 18th Bleeding and Thrombosing Diseases (October 4–6, 2023).

Attendees must register for each conference separately using the "Register now" button on the conference website.

Intended audience

This program is designed for clinicians, pathologists, scientists, nurse practitioners and physician assistants, nurses, and laboratory technologists whose practices include bleeding and thrombosing diseases.

Agenda

Wednesday, Oct. 4, 2023

12:30 p.m. | Registration, Refreshments, and Exhibits

1:20 p.m. | Welcome and Introductions

1:30 p.m. | Overview of Hemostasis: 2023 Update | Sriram Krishnaswamy, Ph.D.

2 p.m. | Hemostasis 101: Basic Refresher and Updates | Justin Kreuter, M.D.

2:30 p.m. | Pediatric Hemostasis: Kids Are Not Little Adults | Ahmad Al-Huniti, M.D.

3 p.m. | Break and Exhibits

3:30 p.m. | Laboratory Tests for Disorders of Primary and Secondary Hemostasis | Dan Dalenberg

4 p.m. | Pre-Analytical Variables for Coagulation Testing | Jansen Seheult, M.B., B.Ch., M.D.

4:30 p.m. | Panel Discussion

5 p.m. | Adjourn

---

Thursday, Oct. 5, 2023

7 a.m. | Breakfast and Exhibits

7:45 a.m. | Ask the Experts Session: Acquired Coagulopathies  

8:30 a.m. | Clinical Updates in Congenital Hemophilia | Mark Reding, M.D.

9 a.m. | Lab Updates in Congenital Hemophilia | Rajiv Pruthi, M.B.B.S.

9:30 a.m. | Gene Therapy | Mark Reding, M.D.

10 a.m. | Break and Exhibits

10:30 a.m. | Rare Congenital Bleeding Disorders | Meera Sridharan, M.D., Ph.D.

11 a.m. | Acquired Factor Inhibitors | Meera Sridharan, M.D., Ph.D.

11:30 a.m. | Panel Discussion 

12 p.m. | Lunch and Exhibits

1 p.m. | Dedication to Dr. William Nichols and Introduction to Session | Rajiv Pruthi, M.B.B.S.

1:30 p.m. | Hereditary von Willebrand Disease | Paula James, M.D., FRCPC

2 p.m. | Acquired von Willebrand Syndrome (AVWS) | Paula James, M.D., FRCPC

2:30 p.m. | Break and Exhibits

3 p.m. | Special Considerations for Women with Bleeding Disorders | Margaret Ragni, M.D., M.P.H.

3:30 p.m. | Hereditary Platelet Disorders - Syndromic and Non-Syndromic | Dong Chen, M.D., Ph.D.

4 p.m. | Genomic Approaches to Bleeding Disorders | Rajiv Pruthi, M.B.B.S.

4:30 p.m. | Panel Discussion

5 p.m. | Adjourn

---

Friday, Oct. 6, 2023

7 a.m. | Breakfast and Exhibits

7:45 a.m. | Ask the Experts Session: Thrombosis in Unusual Locations – Testing and Management

8:30 a.m. | APS and Antiphospholipid Antibody Syndrome | Damon Houghton, M.D., M.S.

9:15 a.m. | Lab Testing | Jansen Seheult, M.B., B.Ch., M.D.

9:45 a.m. | Break and Exhibits

10:15 a.m. | HIT and VITT: Anti-PF4 Antibody-Based Syndromes | Anand Padmanabhan, M.B.B.S., Ph.D.

10:45 a.m. | Oral Anticoagulant Monitoring | Jansen Seheult, M.B., B.Ch., M.D.

11:15 a.m. | Reversal of Anticoagulation | Robert McBane II, M.D.

11:45 a.m. | Panel Discussion

12:15 p.m. | Lunch and Exhibits

1:15 p.m. | Conundrums in von Willebrand Disease | Rajiv Pruthi, M.B.B.S.

1:45 p.m. | Factor XIII Deficiency/Inhibitor | Meera Sridharan, M.D., Ph.D.

2:15 p.m. | Platelet Storage Pool Disorder | Dong Chen, M.D., Ph.D.

2:45 p.m. | Break and Exhibits

3:15 p.m. | Antithrombin Deficiency | Aneel Ashrani, M.D., M.S.

3:45 p.m. | Thrombophilia due to Monoclonal Gammopathy of Thrombotic Significance (MGTS) | Anand Padmanabhan, M.B.B.S., Ph.D.

4:15 p.m. | Panel Discussion

4:45 p.m. | Conference Wrap Up

5 p.m. | Adjourn

Learning objectives

Upon completion of the conference, participants should be able to:

• Summarize clinical features and laboratory evaluation of congenital and acquired bleeding disorders and thrombosing disorders.
• Evaluate antibody-mediated prothrombotic disorders such as heparin-induced thrombocytopenia and other anti-PF4 mediated syndromes, lupus anticoagulant, and antiphospholipid syndrome.
• Discuss special considerations for management of women and bleeding disorders.
• Discuss updates in gene therapy for bleeding disorders.

Faculty

Credit

Credit statement(s):

AMA

Mayo Clinic College of Medicine and Science designates this other activity (live and livestream) activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC

Mayo Clinic College of Medicine and Science designates this activity for a maximum of 16.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ASCLS P.A.C.E.®

Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 16.5 P.A.C.E.® contact hour(s).

State of California

Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for the State of California. This program has been approved for 16.5 contact hour(s).

State of Florida

Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General (Hematology) credit. This program has been approved for 16.5 contact hour(s).

Pharmacology Content

Select presentations will contain pharmacology content. Identified presentations represent approximately 11.00 hours of pharmacology content. Presentations will be identified on the schedule provided at the live conference.

Exhibits and sponsorships

Exhibits will be open during breakfasts, lunches, and breaks. Review the prospectus below for detailed information, including all required paperwork, about exhibiting at this conference.

Travel and lodging

Blocks of rooms have been secured for participants and their guests with special conference rates at the hotels listed below. Reservations can be made using the below links.

The hotels listed are connected by skyway to conference facilities, downtown shops, and restaurants. The Hilton Rochester Mayo Clinic Area is the location of this year’s conference. Group rates will not be available after Monday, Sept. 11, 2023.

There are various ways to travel to Rochester, Minnesota. Please visit Experience Rochester for information on flying and shuttle services available.

Cancellation policy and fine print

If you cancel your participation in this conference on or before Sept. 12, 2023, your registration fee, less a $75 administrative fee, will be refunded. Mayo Clinic Laboratories Education Department must receive written notification of your cancellation. No refunds will be made after Sept. 12, 2023.

Mayo Clinic Laboratories reserves the right to cancel or postpone any conference due to unforeseen circumstances. In the unlikely event Mayo Clinic Laboratories must cancel or postpone this conference, Mayo Clinic Laboratories will refund the registration fee but is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

Fine print

All costs incurred by the registrant such as airline or hotel fees or penalties are the responsibility of the registrant.

Note: By participating in an onsite Mayo Clinic 18th Bleeding and Thrombosing Diseases Conference event, you will be entering an area where livestreaming may occur. By entering Mayo Clinic’s event premises, you consent to video and/or audio recording and their release for livestreaming purposes on the internet by 18th Bleeding and Thrombosing Diseases 2023 Conference event.